Numerous epidemiologic studies of vasectomized men have been conducted over the last decade. The majority of the reports have been reassuring with regard to possible long-term health consequences following male sterilization. In February 1993, two articles suggesting a relationship between vasectomy and prostate cancer appeared in the literature. Following publication of these studies, the United States National Institutes of Health (NIH) organized a meeting of experts to review the most recent literature on vasectomy and prostate cancer. After considering the evidence from the aforementioned studies and the preliminary findings of three unpublished studies, the NIH panel concluded that there was insufficient evidence of a real association between vasectomy and prostate cancer. This article reviews current information concerning the relationship, and recommends that providers continue to provide vasectomy as a contraceptive option. The research community should continue to investigate the possibility of a relationship between vasectomy and prostate cancer.
The February 17, 1993 issue of the Journal of the American Medical Association (JAMA) includes two articles and an editorial on the relationship between vasectomy and prostate cancer [1] [2] [3] . This paper reviews those articles and other research regarding prostate cancer and vasectomy; it also presents conclusions about this issue.
Numerous epidemiologic studies of vasectomy have been conducted over the last decade. These studies have been methodologically diverse and have been conducted by investigators in the United States, United Kingdom and China. They have been generally reassuring with regard to possible long-term health consequences following male sterilization.
In October 1991, following publication of two new case-control studies that suggested an association between vasectomy and prostate cancer [4, 5] , the World Health Organization (WHO) held a meeting that brought together 23 experts from 10 developing and developed countries to review all the available biologic and epidemiologic evidence [6] . The group concluded that any causal relationship between vasectomy and cancer of the prostate or testis is unlikely. These experts considered and rejected proposed theories regarding a biologic mechanism for an association. Because even a slight increase in risk would be of concern, the group made recommendations for further research in this area, but concluded that no changes in family planning policies or practice concerning vasectomy were warranted.
In March 1993, the United States National Institutes of Health organized a meeting of experts [7] to review the most recent literature on vasectomy and prostate cancer. After considering the 1993 JAMA articles and the preliminary findings of three unpublished studies, this group determined that there was no sufficient evidence of a real association between vasectomy and prostate cancer.
Previous studies of vasectomy and prostate cancer
Six previously published US epidemiologic studies have specifically addressed vasectomy as a risk factor for prostate cancer [4, 5, [8] [9] [10] [11] [12] . Three of these studies are hospital-based case-control studies [4, 5, 8] . Because of the case-control study design and the small relative risk detected in these studies, most scientists would be concerned about systematic error, including selection, surveillance and misclassification bias. Two studies were population-based case-control studies [9, 10] . One study included a very small number of cases [9] . The other used a telephone interview method that has the potential for bias due to misclassification by underreporting of exposure among controls [10] .
Sidney et aL [11, 12] and Massey et al. [13] conducted cohort studies. Sidney and co-investigators studied a cohort of 5332 men with a history of vasectomy, each matched to three non-vasectomized men for age, race, marital status, and date and location of the original exam. Mean follow-up from the date of the study intake exam was 6.8 years for vasectomized men; however, the interval between vasectomy and examination was over ten years in 75% of the cohort and over 20 years in 37% of the cohort. The relative risk of prostate cancer among the vasectomized men was 1.0 (95% confidence interval: 0.7-1.6, p-value not reported), both in the original investigation and in the repeated analysis and follow-up five years later.
Massey et al.
[13] studied 10,590 vasectomized men and an equal number of pair-matched controls. Although no information on prostate cancer was presented in the Massey publication, Perlman et al. [14] cited a personal communication from Massey who indicated that there was a decreased relative risk of prostate cancer after eight years of follow-up among the cohort studied. Of the 10,590 men in the cohort, 77% had a postvasectomy interval of 6-12 years, with 22% more than 10 years, and 6% more than 15 years.
An additional cohort study from Great Britain recently reported no relationship between vasectomy and prostate cancer; however, the follow-up period was too short and the cohort too young to allow for meaningful conclusions [14] .
